Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-06 Sale | 2024-02-06 8:18 pm | aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer | 1,590 | $1.69 | $2,687 | 28,321 (Direct) | View |
| 2023-12-11 Purchase | 2023-12-12 6:50 pm | aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO | 15,000 | $1.1764 | $17,646 | 106,173 (Direct) | View |
| 2023-11-10 Purchase | 2023-11-13 4:11 pm | aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO | 15,000 | $1.1136 | $16,703 | 91,173 (Direct) | View |
| 2023-07-28 Purchase | 2023-08-01 4:07 pm | aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO | 15,000 | $2.0149 | $30,224 | 76,173 (Direct) | View |
| 2023-05-10 Purchase | 2023-05-11 09:00 am | aTYR PHARMA INC | LIFE | SCHIMMEL PAUL Director | 200,000 | $2.25 | $450,000 | 1,001,056 (Indirect Direct) | View |
| 2023-02-06 Sale | 2023-02-06 7:00 pm | aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer | 1,566 | $2.36 | $3,696 | 26,710 (Direct) | View |
| 2022-11-21 Purchase | 2022-11-21 9:04 pm | aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO | 10,000 | $2.1405 | $21,405 | 50,798 (Direct) | View |
| 2022-07-01 Purchase | 2022-07-06 5:02 pm | aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO | 15,000 | $2.8776 | $43,164 | 40,798 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-05 Exercise | 2024-02-06 8:20 pm | N/A N/A | aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO | 10,375 | $0 | 137,298 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-06 8:18 pm | N/A N/A | aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer | 3,750 | $0 | 28,321 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-06 8:15 pm | N/A N/A | aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel | 2,688 | $0 | 20,141 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 7:35 pm | N/A 2034-01-05 | aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO | 600,000 | $0 | 600,000 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 7:33 pm | N/A 2034-01-05 | aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer | 150,000 | $0 | 168,661 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 7:30 pm | N/A 2034-01-05 | aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel | 150,000 | $0 | 162,079 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:33 pm | N/A 2033-05-17 | aTYR PHARMA INC | LIFE | Zaknoen Sara Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:32 pm | N/A 2033-05-17 | aTYR PHARMA INC | LIFE | SCHIMMEL PAUL Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:30 pm | N/A 2033-05-17 | aTYR PHARMA INC | LIFE | Lucas Svetlana Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:29 pm | N/A 2033-05-17 | aTYR PHARMA INC | LIFE | Gross Jane A Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:27 pm | N/A 2033-05-17 | aTYR PHARMA INC | LIFE | COUGHLIN TIMOTHY Director | 12,000 | $0 | 18,000 (Direct) | View |
| 2023-05-17 Gift | 2023-05-19 4:27 pm | N/A N/A | aTYR PHARMA INC | LIFE | COUGHLIN TIMOTHY Director | 6,000 | $0 | 18,000 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:23 pm | N/A 2033-05-17 | aTYR PHARMA INC | LIFE | CLARKE JOHN K Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-04-26 Exercise | 2023-04-28 4:56 pm | N/A N/A | aTYR PHARMA INC | LIFE | Zaknoen Sara Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2023-04-26 Exercise | 2023-04-28 4:54 pm | N/A N/A | aTYR PHARMA INC | LIFE | CLARKE JOHN K Director | 6,000 | $0 | 19,797 (Direct) | View |
| 2023-04-26 Exercise | 2023-04-28 4:54 pm | N/A N/A | aTYR PHARMA INC | LIFE | SCHIMMEL PAUL Director | 6,000 | $0 | 801,056 (Direct) | View |
| 2023-04-26 Exercise | 2023-04-28 4:53 pm | N/A N/A | aTYR PHARMA INC | LIFE | Lucas Svetlana Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2023-04-26 Exercise | 2023-04-28 4:52 pm | N/A N/A | aTYR PHARMA INC | LIFE | Gross Jane A Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2023-04-26 Exercise | 2023-04-28 4:51 pm | N/A N/A | aTYR PHARMA INC | LIFE | COUGHLIN TIMOTHY Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 5:08 pm | N/A 2033-02-16 | aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO | 336,096 | $0 | 336,096 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 5:04 pm | N/A 2033-02-16 | aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer | 84,023 | $0 | 84,023 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 5:00 pm | N/A 2033-02-16 | aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel | 84,023 | $0 | 84,023 (Direct) | View |
| 2023-02-03 Exercise | 2023-02-06 7:03 pm | N/A N/A | aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel | 2,688 | $0 | 15,141 (Direct) | View |
| 2023-02-03 Exercise | 2023-02-06 7:00 pm | N/A N/A | aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer | 3,750 | $0 | 26,710 (Direct) | View |
| 2023-02-03 Exercise | 2023-02-06 6:57 pm | N/A N/A | aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO | 10,375 | $0 | 92,298 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:34 pm | N/A 2032-05-24 | aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel | 88,097 | $0 | 91,544 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:32 pm | N/A 2032-05-24 | aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer | 75,347 | $0 | 87,637 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:30 pm | N/A 2032-05-24 | aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO | 516,280 | $0 | 516,280 (Direct) | View |
| 2022-04-26 Option Award | 2022-04-28 7:57 pm | N/A N/A | aTYR PHARMA INC | LIFE | Zaknoen Sara Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2022-04-26 Option Award | 2022-04-28 7:53 pm | N/A N/A | aTYR PHARMA INC | LIFE | SCHIMMEL PAUL Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2022-04-26 Option Award | 2022-04-28 7:50 pm | N/A N/A | aTYR PHARMA INC | LIFE | Lucas Svetlana Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2022-04-26 Option Award | 2022-04-28 7:46 pm | N/A N/A | aTYR PHARMA INC | LIFE | Gross Jane A Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2022-04-26 Option Award | 2022-04-28 7:42 pm | N/A N/A | aTYR PHARMA INC | LIFE | COUGHLIN TIMOTHY Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2022-04-26 Option Award | 2022-04-28 7:39 pm | N/A N/A | aTYR PHARMA INC | LIFE | CLARKE JOHN K Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-07 4:59 pm | N/A 2032-02-03 | aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel | 32,250 | $0 | 32,250 (Direct) | View |